Aortic Repair Devices – Market Insights – Japan

Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Japanese aortic repair device market will grow at a modest rate, which in turn is attributed to shift towards premium-priced endovascular procedures, large and expanding patient pool, and launch of new aortic repair devices in Japan during the forecast period. However, the growth will be limited to some extent by unavailability of certain aortic stent graft brands and pricing pressure due to changes in reimbursement.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Japan from 2019 through 2031.

The emergence of COVID-19 has affected the aortic repair device market in the short term.

How has COVID-19 affect procedure volumes?

What has been the impact on market dynamics?

How quickly procedure volumes are expected to recover?

Aortic repair can be performed using endovascular, surgical, or hybrid procedures.

Which methods are preferred for which indications?

To what extent are hybrid aortic repair procedures being performed for the aortic arch and thoracoabdominal indications in Japan?

How will the launch of new endovascular devices affect the market?

The penetration of endovascular treatment methods for aortic repair is growing.

What are the main drivers and limiters of growth in the Japanese endovascular aortic repair device market?

Which indication has seen the highest penetration of endovascular treatments?

For which indications will uptake of endovascular aortic repair procedures be limited and why?

MHLW reimbursement revisions are affecting the Japanese aortic repair device market.

Which segments are being affected by the revisions?

What other factors will affect ASP trends?

Changes in the regulatory landscape will impact the Japanese aortic repair device market.

Which aortic repair devices were the first to be evaluated under HTAs?

How will increasing emphasis on cost-effectiveness data for Japanese reimbursement decisions impact the aortic repair device market?

How will recent regulatory changes affect the device approval process?

Table of contents